Chrysotile asbestos as a cause of mesothelioma: Application of the Hill causation model

International Journal of Occupational and Environmental Health

Volumn 10, Issue 2, 2004, Pages 233-239

  Lemen, Richard A ^a  

^a NONE

Author keywords

Amphiboles; Asbestos; Causation; Chrysotile; Hill model; Mesothelioma

Indexed keywords

ASBESTOS; CHRYSOTILE;

CANCER INCIDENCE; CANCER RISK; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL HEALTH; ENVIRONMENTAL PROTECTION; EPIDEMIOLOGICAL DATA; HEALTH CARE POLICY; HUMAN; PLEURA MESOTHELIOMA; PRIORITY JOURNAL; PROBLEM SOLVING; PUBLIC HEALTH SERVICE; REVIEW;

EID: 0842307903     PISSN: 10773525     EISSN: None     Source Type: Journal    
DOI: 10.1179/oeh.2004.10.2.233     Document Type: Review

References (80)

1. Greenland S. Causation. In: Gail MH, Benichou J (eds). Encyclopedia of Epidemiologic Methods. Chichester, U.K.: John Wiley & Sons, 2000; 182-5.
2. Hill B. The environment and disease: association or causation? Proc R Soc Med. 1965; 58:295-9.
3. Tossavainen A, et al. Consensus Report, "Asbestos, asbestosis, and cancer: the Helsinki criteria for diagnosis and attribution." Scand J Work Environ Health. 1997; 23:311-6.
4. IPCS. Environmental Health Criteria 203: Chrysotile Asbestos, International Program on Chemical Safety, World Health Organization, 1998.
5. IARC, IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man - Asbestos Volume 14. International Agency for Research on Cancer, World Health Organization, Lyon, France, 1977.
6. Dupre JS, Mustard JF, Uffen RJ. Report of the Royal Commission on Matters of Health and Safety Arising from the Use of Asbestos in Ontario. Ontario Ministry of the Attorney General, Toronto, ON, Canada: Queen's Printer for Ontario, 1984.
7. Roggli VL, Sanfilippo F, Shelburne JD. Mesothelioma. Chapter 5. In: Roggli VL, Greenberg SD, Pratt PC (eds), Pathology of Asbestos-Associated Diseases. Boston/Toronto/London: Little, Brown & Company, 1992.
8. Mullan RJ, Murthy LM, Occupational sentinel health events: an up-dated list for physician recognition and public health surveillance. Am J Ind Med. 1991; 19:775-99.
9. NIOSH. Report to Congress on Workers' Home Contamination Study Conducted under the Workers' Family Protection Act (29 U.S.C. 671a). National Institute for Occupational Safety and Health, Cincinnati, OH, U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention, September 1995.
10. Hillerdal G, Mesothelioma: cases associated with non-occupational and low dose exposures. Occup Environ Med. 1999; 56: 505-13.
11. Piolatto G, Negri E, La Veccia C, Pira E, Decarli A, Pero J. An update of cancer mortality among chrysotile asbestos miners in Balangero, Northern Italy. Br J Ind Med. 1990; 47:810-4.
12. Cullen M, Baloyi R. Chrysotile asbestos and health in Zimbabwe: I. Analysis of miners and millers compensated for asbestos-related diseases since independence. 1980. Am J Ind Med. 1991; 19:161-9.
13. Baloyi R. Exposure to asbestos among chrysotile miners, millers, and mine residents and asbestosis in Zimbabwe, Academic dissertation, University of Kuopic, Helsinki, Finland, 1989.
14. Kohyama N, Shinohara Y, Suzuki Y. Mineral phases and some reexamined characteristics of International Union Against Cancer standard asbestos samples. Am J Ind Med. 1996; 30:515-28.
15. Rogers AJ, Leigh J, Berry G, Ferguson DA, Mulder HB, Ackad M. Relationship between lung asbestos fiber type and concentration and relative risk of mesothelioma, a case-control study. Cancer. 1991; 67:1912-20.
16. Henderson DW. Discussion of in European Communities - Measures Affecting Asbestos and Asbestos-Containing Products - Report of the Panel, World Trade Organization (WTO), 18 September, 2000:273.
17. Yano E, Wang Z-M, Wang X-R, Wang M-Z, Lan Y-J. Cancer mortality among workers exposed to amphibole-free chrysotile asbestos. Am J Epidemiol. 2001; 154:538-43.
18. Camus M, Siemiatycki J, Meek B. Nonoccupational exposure to chrysotile asbestos and the risk of cancer. N Engl J Med. 1998; 338:1565-71.
19. Camus M, Siemiatycki J, Case BW, Desy M, Richardson L, Campbell S. Risk of mesothelioma among women living near chrysotile mines versus USEPA asbestos risk model: preliminary findings. Ann Occup Hyg. 2002; 46:95-8.
20. Nokso-Koivisto P, Pukkala E. Past exposure to asbestos and combustion products and incidence of cancer among Finnish locomotive drivers. Occup Environ Med. 1994; 51:330-4.
21. Tuomi T. Asbestos Exposure of Finnish Mesothelioma Patients. Electron microscopic analysis of mineral fibers in lung tissue and bronchoalveolar lavage fluid. Kuopio, Institute of Occupational Health & University of Kuopio, Helsinki, Finland, 1991.
22. Selikoff IJ. Historical developments and perspectives in inorganic fiber toxicity in man. Environ Health Perspect. 1990; 88: 269-76.
23. Meurman LO, Kiviluoto R, Hakama M. Mortality and morbidity among the working population of anthophyllite asbestos miners in Finland. Br J Ind Med. 1974; 31:105.
24. Nurminen M. The epidemiologic relationship between pleural mesosthelioma and asbestos exposure. Scand J Work Environ Health. 1975; 1:128-37.
25. Huuskonen MS, Ahlman K, Mattson T, Tossavainen A. Asbestos disease in Finland. J Occup Med. 1980; 22:751-4.
26. Tuomi T, Segerberg-Knottinen M, Tammilehto L, Tossavainen A, Vanhala E. Mineral fiber concentration in lung tissue of mesothelioma patients in Finland. Am J Indust Med. 1989; 16: 247-54,
27. Churg A. Chrysotile, tremolite and malignant mesothelioma in man. Chest. 1988; 93:621-8.
28. Kaarjalainen A, Meurman LO, Pukkala E. Four cases of mesothelioma among Finnish anthophyllite miners. Occup Environ Med. 1994; 51:212-5.
29. Meurman LO, Pukkala E, Hakama M. Incidence of cancer among anthophyllite asbestos miners in Finland. Occup Environ Med. 1994; 51:421-5.
30. Mancuso TF. Relative risk of mesothelioma among railroad machinists exposed to chrysotile. Am J Ind Med. 1988; 13:639-57.
31. Robinson CF, Lemen RA, Wagoner JK. Mortality patterns, 1940-1975 among workers employed in an asbestos textile friction and packing products manufacturing facilities. In: Lemen RA, Dement JM (eds), Dust and Disease. Park Forest, IL: Pathotox Publishers, 1979: 131-43.
32. Sturm W, Menze B, Krause J, Thriene B. Use of asbestos, health risks and induced occupational diseases in the former East Germany. Toxicol Lets. 1994; 72:317-24.
33. Rodelsperger K, Jockel K-H, Pohlabeln H, Romer W Woitowitz, H-J. Asbestos and man-made vitreous fibers as risk factors for diffuse malignant mesothelioma: results from a German hospital-based case-control study. Am J Ind Med. 2001; 39:262275.
34. Iwatsubo Y, Pairon JC, Boutin O, et al. Pleural mesothelioma: dose-response relation at low lwvels of asbestos exposure in a French population-based case-control study. Am J Epidemiol. 1998; 148:133-42.
35. Cartier P. Abstract of discussion. Arch Ind Hyg Occup Med. 1971; 5:262, and Champion P. Two cases of malignant mesothelioma after exposure to asbestos. Am Rev Respir Dis. 1952; 103: 821-6.
36. Cartier P. Abstract of discussion. Arch Ind Hyg Occup Med. 1971; 5:262, and Champion P. Two cases of malignant mesothelioma after exposure to asbestos. Am Rev Respir Dis. 1952; 103: 821-6.
37. Hughes J, Weill H, Hammad Y. Mortality of workers employed in two asbestos cement manufacturing plants. Br J Ind Med. 1986; 44:161-74.
38. Dement JM, Harris RL, Symores NJ, Shy CM. Exposure and mortality among chrysotile asbestos workers. Part II: Mortality. Am J Ind Med. 1983; 4:321.
39. Borrow W, Coston A, Livernese L, et al. Mesothelioma following exposure to asbestos: a review of 72 cases. Chest. 1973; 64:641-6.
40. Teta MJ, Lewinsohn HC, Meigs JW, Vidone RA, Mowad LZ. Mesothelioma in Connecticut, 1955-1977. J Occup Med. 1983; 25:749-56.
41. Newhouse M, Sullivan KR. A mortality study of workers manufacturing friction materials: 1941-86. Br J Ind Med. 1989; 46: 176-9.
42. Konetzke GW, Beck B, Herold HJ. Asbestos-induced Mesothelioma-Results of a Retrospective Study. Proceedings of the International Symposium on the Prevention of Occupational Cancer, Helsinki, Finland, 1981.
43. Vienna NJ, Polen A. Non-occupational exposure to asbestos and malignant mesothelioma in females. Lancet. May 20, 1978; 1061-3.
44. Leigh J, Driscoll T. Malignant mesothelioma in Australia, 1945-2002. Int J Occup Environ Health., 2003; 9:206.
45. McDonald AC, Harper A, Attar OA, McDonald JC. Epidemiology of primary malignant mesothelial tumors in Canada. Cancer. 1970; 26:914-9.
46. Langer AM, McCaughey WTE. Mesothelioma in a brake repair worker. Lancet. 1982; 2:1101-3.
47. Kagan E, Jacobson RJ. Lymphoid and plasma cell malignancies: asbestos-related disorders of long latency. Am J Clin Pathol. 1983; 80:14-20.
48. Huncharek M, Muscat J, Capotorto J. Pleural mesothelioma in a brake lift mechanic. Br J Ind Med. 1989; 46:69-71.
49. Greenberg M, Lloyd-Davies TA. Mesothelioma Register 1967-68. Br J Ind Med. 1974; 31:91-104.
50. Hansen ES. Mortality of auto mechanics, a ten year follow-up. Scand J Work Environ Health. 1989; 15:41-6.
51. Maltoni C, Pinto C, Mobiglia A. Mesotheliomas due to asbestos used in railroads in Italy. The third wave of asbestos disease: exposure to asbestos in place. Ann NY Acad Sci. 1991; 643:347-415.
52. Ruttner J. Discussion: Part II, Ann NY Acad Sci. 1991; 643:415.
53. Scansetti G, Mollo F, Tiberi G Andrion A, Piolatto G. Pleural mesothelioma after a short interval from first exposure in the wine filter industry. Am J Ind Med. 1984; 5:335-9.
54. Lieben J, Pistawiza R. Mesothelioma and asbestos exposure. Arch Environ Health. 1967; 14:559-66.
55. Wolf KM, Piotrowski ZH, Eagle JD, Bekeris LG, Palacios E, Fisher KA. Malignant mesothelioma with occupational and environmental asbestos exposure in an Illinois community hospital. Arch Intern Med. 1987; 147:2145-9.
56. Monson RR. Occupation. In: Schottenfeld D, Fraumeni JF Jr (eds). Cancer Epidemiology and Prevention. 2nd ed. New York and Oxford: Oxford University Press, 1996: 373-405.
57. Stanton MF, Wrench C. Mechanisms of mesothelioma induction with asbestos and fibrous glass. J Natl Cancer Inst. 1972; 48:797-821.
58. Stanton MF, Laynard M, Tegeris A, et al. Relation of particle dimension to carcinogenicity in amphibole asbestoses and other fibrous minerals. J Natl Cancer Inst. 1981; 67:965-75.
59. Dement JM, Brown DP. Cohort mortality and case-control studies of white male chrysotile asbestos textile workers. J Occup Med Toxicol. 1993; 2:355-63.
60. Sebastien P, McDonald JC, McDonald AD, Case B, Harley R. Respiratory cancer in chrysotile textile and mining industries: exposure inferences from lung analysis. Br J Ind Med. 1989; 46: 180-7.
61. Mutsaers SE. The mesothelial cell. Int J Biochem Cell Biol. 2004; 36:9-16.
62. Suzuki Y, Kolynema N. Translocation of inhaled asbestos fibers from the lung to other tissues. Am J Ind Med. 1991; 19:701-4
63. Kohyama N, Suzuki Y. Analysis of asbestos fibers in lung parenchyma, pleural plaques, and mesothelioma tissues of North American insulation workers. Ann NY Acad Sci. 1991; 643:27-52.
64. Suzuki Y, Yuen S, Ashley R, Calderato A. Asbestos fibers and human malignant mesothelioma. In: Chiyotani K, Hoaoda YI, Aizawa Y (eds). Advances in the Prevention of Occupational Respiratory Diseases. New York: Elsivier Science B.V., 1998: 709-13.
65. Sebastien PI, Janson X, Gausichet A, Hirsch A, Bigno J. Asbestos retention in human respiratory tissues: comparative measurements in lung parenchyma and in parietal pleura. IARC Sci Pub. 1980; 30:237-46.
66. Malorni W, Losi F, Falcini M, Donelli G. On the mechanism of cell internalization of chrysotile fibers. An immunccytechnical and ultrastructural study. Environ Res. 1990; 52:164-77.
67. Leversse V, Renier A, Fleury-Feith J, et al. Analysis of cell cycle disruptions in cultures of rat pleural mesothelial cells exposed to asbestos fibers. Am J Respir Cell Molec Biol. 1997; 17:660-71.
68. Wagner JC, Berry G, Skidmore JW, Poole FD. The comparative effects of three chrysotiles by injection and inhalation in rats. In: Biological Effects of Mineral Fibers. Vol. 1, International Agency for Research on Cancer, Lyon, France. IARC Scientific Publications No. 30, World Health Organization. 1980; 363-72.
69. Wagner JC, Berry G, Timbrell V. Mesothelioma in rats following inoculation with asbestos and other materials. Br J. Cancer. 1973; 28:173-85.
70. Wagner JC, Berry G, Skidmore JW, Timbrell V. The effects of the inhalation of asbestos in rats. BrJ Cancer. 1974; 29:252-69.
71. Craighead J, Aldey NY, Gould LB, Libbus BL. Characteristics of tumors and tumor cells cultured from experimental asbestos-induced mesotheliomas in rats. Am J Pathol. 1987; 129448-62.
72. Frank AL, Dodson RR, Williams MG. Carcinogenic implications of the lack of tremolite in UICC reference chrysotile. Am J Ind Med. 1998; 34:314-7.
73. Kohyana N, Shinohara Y, Suzuki YI. Mineral plants and some reexamined characteristics of the International Union Against Cancer standard asbestos samples. Am J Ind Med. 1996; 30:515-28.
74. McDonald JC. Mineral fibre persistence and carcinogenicity. Ind Health. 1998; 36:372-5.
75. McDonald JC, McDonald AD. Chrysotile, tremolite and carcinogenicity. Ann Occup Hyg. 1997; 41:699-705.
76. Bolton RE, Davis JMG, Donaldson K, Wright A. Variations in the carcinogenicity of mineral fibres. Am Occup Hyg. 1982; 126: 569-82.
77. Minardi F, Maltoni C. Results of recent experimental research on the carcinogenicity of natural and modified asbestos. Ann NY Acad Sci. 1988; 5634:754-61.
78. Stayner LT, Dankovic DA, Lemen RA. Occupational exposure to chrysotile asbestos and cancer risk: a review of the amphibole hypothesis. Am J Public Health. 1996; 86:179-86.
79. Landrigan PJ, Nicholson WJ, Suzuki Y, Ladou J. The hazards of chrysotile asbestos: a critical review. Ind Health. 1999; 37:271-80.
80. Hodgson JT, Darnton A. The quantitative risks of mesothelioma and lung cancer in relation to asbestos exposure. Ann Occup Hyg. 2000; 44:565-601.